Sinobiopharma, Inc. (fka SNBP)

[pappy]

Looks like we may not see earnings until around the 15th Sept. the date they reported last year.

This delay sure isn't helping the current pps.

However I expect that they will meet or beat their own projected eps of $0.03 for 2010.

And with many new drugs coming to market 2011 should be a very strong year of growth.

I would like to see two things change in 2011.

1] Slower increase in shares outstanding.

2] Start reporting on time.

Those two changes would not only increase bottom-line eps to at least $0.07 in 2011 but should also get the pps over a buck.

Once over a buck a reverse split to facilitate listing could bring in the capitol needs to finance future growth with far less future dilution.

Enough rambling for today...pappy,,,out.